Pharmacokinetics, tissue distribution and relative bioavailability of isoniazid-solid lipid nanoparticles

International Journal of Pharmaceutics

Volumn 441, Issue 1-2, 2013, Pages 202-212

  Bhandari, Rohit ^a   Kaur, Indu Pal ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Bioavailability; Isoniazid; Pharmacokinetics; Solid lipid nanoparticles; Tuberculosis

Indexed keywords

ISONIAZID; SOLID LIPID NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG RELEASE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIVER TOXICITY; NEUROTOXICITY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; RETICULOENDOTHELIAL SYSTEM; SINGLE DRUG DOSE; TISSUE DISTRIBUTION; TISSUE HOMOGENATE; ZETA POTENTIAL;

ADMINISTRATION, ORAL; ANIMALS; ANTITUBERCULAR AGENTS; BIOLOGICAL AVAILABILITY; BRAIN; DELAYED-ACTION PREPARATIONS; DRUG-INDUCED LIVER INJURY; FEMALE; ISONIAZID; LETHAL DOSE 50; LIPIDS; NANOPARTICLES; PARTICLE SIZE; RATS; RATS, WISTAR; TISSUE DISTRIBUTION;

EID: 84872764574     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.11.042     Document Type: Article

References (85)

1. Anon. Tuberculosis 2010 Encylopedia Britanica http://www.britannica.com/ EBchecked/topic/608235/tuberculosis/253299/Tuberculo
2. S. Agrawal, I. Singh, K.J. Kaur, S.R. Bhade, C.L. Kaul, and R. Panchagnula Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levels Int. J. Pharm. 276 2004 41 49
3. A. Albanese, P.S. Tang, and W.C.W. Chan The effect of nanoparticle size, shape, and surface chemistry on biological systems Annu. Rev. Biomed. Eng. 14 2012 1 16
4. A.J. Almeida, S. Runge, and R.H. Miiller Peptide-loaded solid lipid nanoparticles (SLN): influence of production parameters Int. J. Pharm. 149 1997 255 265
5. R.N. Alyautdin, V.E. Petrov, K. Langer, A. Berthold, D.A. Kharkevich, and J. Kreuter Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles Pharm. Res. 14 1997 325 328
6. A. Ambruosi, S. Gelperina, A. Khalansky, S. Tanski, A. Theisen, and J. Kreuter Influence of surfactants, polymer and doxorubicin loading on the anti-tumour effects of poly(butyl cyanoacrylate) nanoparticles in a rat glioma model J. Microencapsul. 23 2006 582 592
7. C. Becker, J.B. Dressman, G.L. Amidon, H.E. Junginger, S. Kopp, K.K. Midha, V.P. Shah, S. Stavchansky, and D.M. Barends Biowaiver monographs for immediate release solid oral dosage forms: isoniazid J. Pharm. Sci. 96 2007 522 531
8. Bhandari, R., Kaur, I.P., 2012a. A method to prepare solid lipid nanoparticles with improved entrapment efficiency of hydrophilic drugs. Curr. Nanosci., http://dx.doi.org/CNANO-EPUB-20120810-1.
9. R. Bhandari, and I.P. Kaur A sensitive HPLC method for determination of isoniazid in rat plasma, brain, liver and kidney J. Chromatogr. Sep. Tech. 3 2012 10.4172/2157-7064.1000128
10. M. Black, J.R. Mitchell, H.J. Zimmerman, K.G. Ishak, and G.R. Epler Isoniazid associated hepatitis in 114 patients Gastroenterology 69 1975 289 302
11. I.e.a. Brigger Negative preclinical results with stealth nanospheres encapsulated doxorubicin in an orthopic murine brain tumor model J. Control. Release 100 2004 29 40
12. R. Cavalli, O. Caputo, and M.R. Gasco Preparation and characterization of solid lipid nanospheres containing paclitaxel Eur. J. Pharm. Biopharm. 10 2000 305 330
13. Y. Chen, G. Dalwadi, and H.A.E. Benson Drug delivery across the blood-brain barrier Curr. Drug Deliv. 1 2004 361 376
14. B.D. Chithrani, and W.C. Chan Elucidating the mechanism of cellular uptake and removal of protein coated gold nanoparticles of different sizes and shapes Nano Lett. 7 2007 1542 1550
15. B.D. Chithrani, A.A. Ghazani, and W.C. Chan Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells Nano Lett. 6 2006 662 668
16. R. Cortesi, E. Esposito, G. Luca, and C. Nastruzzi Production of lipospheres as carriers for bioactive compounds Biomaterials 23 2002 2283 2294
17. V.A. Desai, and S.B. Agarwal Isoniazid toxicity JIACM 5 2004 83 85
18. S. Devadatta, P.R.J. Gangadharam, R.H. Andrews, W. Fox, C.V. Ramakrishnan, J.B. Selkon, and S. Velu Peripheral neuritis due to isoniazid Bull. World Health Organ. 23 1960 587 598
19. K. Duncan, and C.E. Barry Prospects for new antitubercular drugs Curr. Opin. Microbiol. 7 2004 460 465
20. G.A. Ellard, and P.T. Gammon Pharmacokinetics of isoniazid metabolism in man J. Pharmacokinet. Pharmacodyn. 4 1976 83 113
21. K. Florey Analytical profiles of drug substances: isoniazid Acad. Pharm. Sci. 6 2006 183 258
22. A. Fundaro, R. Cavalli, A. Bagoni, D. Vighetto, G.P. Zara, and M.R. Gasco Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats Pharm. Res. 42 2000 337 343
23. H. Gao, W. Shi, and L.B. Freund Mechanics of receptor-mediated endocytosis Proc. Natl. Acad. Sci. U. S. A. 102 2005 9469 9474
24. S.H. Gohla, and A. Dingler Scaling up feasibility of the production of solid lipid nanoparticles (SLN™) Pharmazie 56 2001 61 63
25. R.C. Goldman, and B.E. Laughon Discovery and validation of new antitubercular compounds as potential drug leads and probes Tuberculosis 89 2009 331 333
26. S.E. Gratton, P.A. Ropp, P.D. Pohlhaus, J.C. Luft, and V.J. Madden The effect of particle design on cellular internalization pathways Proc. Natl. Acad. Sci. U. S. A. 105 2008 11613 11618
27. C. Higgins The Use of Heparin in Preparing Samples for Blood-gas Analysis 2007 www.mlo-online.com/articles/1007/1007cover-story.pdf (accessed 22.06.12)
28. L. Hu, X. Tang, and F. Cui Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drug J. Pharm. Pharmacol. 56 2004 1527 1535
29. V. Jenning, A. Lippacher, and S.H. Gohla Medium scale production of solid lipid nanoparticles (SLN) by high pressure homogenization J. Microencapsul. 19 2002 1 10
30. L. Jie, G. Tao, W. Changguang, Z. Zhirong, and Z. Zhirong Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization Int. J. Pharm. 340 2007 153 162
31. H. Jin, D.A. Heller, R. Sharma, and M.S. Strano Size-dependent cellular uptake and expulsion of single-walled carbon nanotubes: single particle tracking and a generic uptake model for nanoparticles ACS Nano 3 2009 149 158
32. V. Kakkar, A.K. Mishra, K. Chuttani, K. Chopra, and I.P. Kaur Delivery of sesamol-loaded solid lipid nanoparticles to the brain for menopause-related emotional and cognitive central nervous system derangements Rejuvenation Res. 14 2011 597 604
33. V. Kakkar, S. Singh, D. Singla, and I.P. Kaur Solid lipid nanoparticles to enhance the oral bioavailability of curcumin Mol. Nutr. Food Res. 54 2010 10.1002/mnfr.201000310
34. K.C. Kang, C.I. Lee, H.B. Pyo, and N.H. Jeong Preparation and characterization of nano-liposomes using phosphatidylcholine J. Ind. Eng. Chem. 11 2005 847 851
35. B.C.P. Kante, G. Dubois-Krack, and C. De Meester Toxicity of polyalkylcyanoacrylate nanoparticles J. Pharm. Sci. 71 1982 786 789
36. Kaur, I.P., Bhandari, R., 2012a. Solid lipid nanoparticles entrapping hydrophilic/amphiphilic drug and a process for preparing the same. Indian patent application number: 127/DEL/2012 (dated January 13, 2012).
37. Kaur, I.P., Bhandari, R., 2012b. Solid lipid nanoparticles entrapping hydrophilic/amphiphilic drug and a process for preparing the same. PCT application number: PCT/IN2012/000154 (dated March 5, 2012).
38. I.P. Kaur, R. Bhandari, S. Bhandari, and V. Kakkar Potential of solid lipid nanoparticles in brain targeting J. Control. Release 127 2008 97 109
39. J. Kreuter Nanoparticulate system for brain delivery of drugs Adv. Drug Deliv. Rev. 47 2001 65 81
40. G.S. Lee, D.H. Lee, K.C. Kang, C.I. Lee, H.B. Pyo, and T.B. Choi Preparation and characterization of bis-ethylhexyloxyphenolmethoxyphenyltriazine (BEMT) loaded solid lipid nano-particles (SLN) J. Ind. Eng. Chem. 13 2007 1180 1187
41. S. Lim, M. Lee, and C. Kim Altered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticle powders J. Control. Release 100 2004 53 61
42. I. Limayem, C. Charcosset, and H. Fessi Purification of nanoparticle suspension by a concentration/diafiltration process Sep. Purif. Technol. 38 2004 1 9
43. A. Lippacher, R.H. Müller, and K. Mäderb Liquid and semisolid SLNe dispersions for topical application: rheological characterization Eur. J. Pharm. Biopharm. 58 2004 561 567
44. P.R. Lockman, M.O. Oyewumi, J.M. Koziara, K.E. Roder, R.J. Mumper, and D.D. Allen Brain uptake of thiamine-coated nanoparticles J. Control. Release 93 2003 271 282
45. N. Lounis, C. Truffot-pernot, A. Bentoucha, J. Robert, B. Ji, and J. Grosset Efficacies of clarithromycin regimens against Mycobacterium xenopi in mice Antimicrob. Agents Chemother. 45 2001 3229 3230
46. F. Lu, S.H. Wu, Y. Hung, and C.Y. Mou Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles Small 5 2009 1408 1413
47. Y. Luo, D. Chen, L. Ren, X. Zhao, and J. Qin Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability J. Control. Release 114 2006 53 59
48. W.C. Maddrey, and J.K. Boitnott Isoniazid hepatitis Ann. Intern. Med. 79 1973 1 12
49. T.T. Mariappan, and S. Singh Regional gastrointestinal permeability of rifampicin and isoniazid (alone and their combination) in the rat Int. J. Tuberc. Lung Dis. 7 2003 797 803
50. S. Maryam, A.S.A. Bhatti, and A.W. Shahzad Protective effects of silymarin in isoniazid induced hepatotoxicity in rabbits Annals 16 2010 43 47
51. I.G. Metushi, P. Cai, X. Zhu, T. Nakagawa, and J.P. Uetrecht A fresh look at the mechanism of isoniazid-induced hepatotoxicity Clin. Pharmacol. Ther. 89 2011 911 914
52. S.M. Moghimi, A.C. Hunter, and J.C. Murray Long-circulating and target-specific nanoparticles: theory to practice Pharmacol. Rev. 53 2001 283 318
53. S. Morel, E. Ugazio, R. Cavalli, and M.R. Gasco Thymopentin in solid lipid nanoparticles Int. J. Pharm. 132 1996 259 261
54. R. Nair, K.V. Priya, K.S. Arun Kumar, T.M. Badivaddin, and M. Sevukarajan Formulation and evaluation of solid lipid nanoparticles of water soluble drug: isoniazid J. Pharm. Sci. Res. 3 2011 1256 1264
55. A.P. Nayak, W. Tiyaboonchai, S. Patankar, B. Madhusudhan, and E.B. Souto Curcuminoids-loaded lipid nanoparticles: novel approach towards malaria treatment Colloids Surf. B: Biointerfaces 81 2010 263 273
56. C. Olbrich, A. Gessner, W. Schröder, O. Kayser, and R.H. Müller Lipid-drug conjugate nanoparticles of the hydrophilic drug diminazene- cytotoxicity testing and mouse serum adsorption J. Control. Release 96 2004 425 435
57. J.C. Olivier Drug transport to brain with targeted nanoparticles NeuroRx 2 2005 108 119
58. R. Paliwal, S. Rai, B. Vaidya, K. Khatri, A.K. Goyal, N. Mishra, A. Mehta, and S.P. Vyas Effect of lipid core material on characteristics of solid lipid nanoparticles designed for oral lymphatic delivery Nanomedicine 5 2009 184 191
59. R. Pandey, and G.K. Khuller Oral nanoparticle-based antituberculosis drug delivery to the brain in an experimental model J. Antimicrob. Chemother. 57 2006 1146 1152
60. R. Pandey, S. Sharma, and G.K. Khuller Oral solid lipid nanoparticle-based antitubercular chemotherapy Tuberculosis 85 2005 415 420
61. R. Pandey, S. Sharma, and G.K. Khuller Chemotherapeutic efficacy of nanoparticle encapsulated antitubercular drugs Drug Deliv. 13 2006 287 294
62. R. Pandey, A. Zahoor, R. Pandey, S. Sharma, and G.K. Khuller Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis Tuberculosis 83 2003 373 378
63. J. Panyam, and V. Labhasetwar Dynamics of endocytosis and exocytosis of poly(d,l-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells Pharm. Res. 20 2003 212 220
64. C.A. Peloquin, R. Namdar, A.A. Dodge, and D.E. Nix Pharmacokinetics of isoniazid under fasting conditions, with food, and with antacids Int. J. Tuberc. Lung Dis. 3 1999 703 710
65. Y. Qiu, Y. Liu, L.M. Wang, L.G. Xu, and R. Bai Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods Biomaterials 31 2010 7606 7619
66. M. Rawat, S. Manju, D. Singh, and S. Saraf Lipid carriers: a versatile delivery vehicle for proteins and peptides Yakugaku Zasshi 128 2008 269 280
67. H. Reddy, and R.S.R. Murthy Etoposide-loaded nanoparticles made from glyceride lipids: formulation, characterization, in vitro drug release, and stability evaluation AAPS PharmSciTech 6 2005 E158 E166
68. J.S. Reddy, and V. Venkateshwarlu Novel delivery systems for drug targeting to the brain Drugs Fut. 29 2004 63 83
69. H. Reithmeier, J. Herrmann, and A. Gopferich Lipid microparticles as a parenteral controlled release device for peptides J. Control. Release 73 2001 339 350
70. B. Rubin, and J.C. Burke Absorption, distribution and excretion of isoniazid (nydrazid) in the dog J. Pharmacol. Exp. Ther. 107 1952 219 224
71. R. Sankar, N. Sharda, and S. Singh Behaviour of decomposition of rifampicin in the presence of isoniazid in the pH range 1-3 Drug Dev. Ind. Pharm. 29 2003 733 738
72. T.C. Sarich, M. Youssefi, T. Zhou, S.P. Adams, R.A. Wall, and J.M. Wright Role of hydrazine in the mechanism of isoniazid hepatotoxicity in rabbits Arch. Toxicol. 70 1996 835 840
73. T.C. Sarich, T. Zhou, S.P. Adams, A.I. Bain, R.A. Wall, and J.M. Wright A model of isoniazid-induced hepatotoxicity in rabbits J. Pharmacol. Toxicol. Methods 34 1995 109 116
74. C. Schwarz, W. Mehnert, J.S. Lucks, and R.H. Muller Solid lipid nanoparticles for controlled drug delivery. I. Production, characterization and sterilization J. Control. Release 30 1994 83 96
75. N. Seetapan, P. Bejrapha, W. Srinuanchai, and U.R. Ruktanonchai Rheological and morphological characterizations on physical stability of gamma-oryzanol-loaded solid lipid nanoparticles (SLNs) Micron 41 2010 51 58
76. C.J. Shishoo, S.A. Shah, I.S. Rathod, S.S. Savale, and M.J. Vora Impaired bioavailability of rifampicin in presence of isoniazid from fixed dose combination (FDC) formulation Int. J. Pharm. 228 2001 53 67
77. S. Singh, A.K. Dobhal, A. Jain, J.K. Pandit, and S. Chakraborty Formulation and evaluation of solid lipid nanoparticles of a water soluble drug: zidovudine Chem. Pharm. Bull. 58 2010 650 655
78. S. Singh, A.K. Dobhal, A. Jain, P.K. Pandit, and S. Chakarborty Formulation and evaluation of solid lipid nanoparticles of a water soluble drug: zidovudine Chem. Pharm. Bull. 58 2010 650 655
79. K. Tabatt, C. Kneuer, M. Sameti, C. Olbrich, R.H. Müller, C.M. Lehr, and U. Bakowsky Transfection with different colloidal systems: comparison of solid lipid nanoparticles and liposomes J. Control. Release 97 2004 321 332
80. A. Tostmann, M.J. Boeree, R.E. Aarnoutse, W.C.M.D. Lange, A.J.A.M.V. Ven, and R. Dekhuijzen Antituberculosis drug-induced hepatotoxicity: concise up-to-date review J. Gastroenterol. Hepatol. 23 2008 192 202
81. K. Westesen, H. Bunjas, and M.H.J. Koch Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential J. Control. Release 48 1997 223 236
82. H.J. Yang, W.G. Cho, and S.N. Park Stability of oil-in-water emulsions prepared using the phase inversion composition method J. Ind. Eng. Chem 15 2009 331
83. H.Y. Yuan, J. Li, G. Bao, and S.L. Zhang Variable nanoparticle-cell adhesion strength regulates cellular uptake Phys. Rev. Lett. 105 2010 1138101 1381014
84. A. Zensi, D. Begley, C. Pontikis, C. Legros, L. Mihoreanu, S. Wagner, C. Büchel, H.V. Briesen, and J. Kreuter Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones J. Control. Release 137 2009 78 86
85. S. Zhang, J. Li, G. Lykotrafitis, G. Bao, and S. Suresh Size-dependent endocytosis of nanoparticles Adv. Mater. 21 2009 419 424